IBDEI365 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50599,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,50599,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,50599,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,50600,0)
 ;;=I38.^^193^2496^4
 ;;^UTILITY(U,$J,358.3,50600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50600,1,3,0)
 ;;=3^Endocarditis,Valve Unspec
 ;;^UTILITY(U,$J,358.3,50600,1,4,0)
 ;;=4^I38.
 ;;^UTILITY(U,$J,358.3,50600,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,50601,0)
 ;;=I05.0^^193^2496^18
 ;;^UTILITY(U,$J,358.3,50601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50601,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,50601,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,50601,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,50602,0)
 ;;=I05.8^^193^2496^19
 ;;^UTILITY(U,$J,358.3,50602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50602,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease NEC
 ;;^UTILITY(U,$J,358.3,50602,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,50602,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,50603,0)
 ;;=I05.9^^193^2496^20
 ;;^UTILITY(U,$J,358.3,50603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50603,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,50603,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,50603,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,50604,0)
 ;;=I07.1^^193^2496^21
 ;;^UTILITY(U,$J,358.3,50604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50604,1,3,0)
 ;;=3^Rheumatic Tricuspid Insufficiency
 ;;^UTILITY(U,$J,358.3,50604,1,4,0)
 ;;=4^I07.1
 ;;^UTILITY(U,$J,358.3,50604,2)
 ;;=^5007048
 ;;^UTILITY(U,$J,358.3,50605,0)
 ;;=I07.9^^193^2496^22
 ;;^UTILITY(U,$J,358.3,50605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50605,1,3,0)
 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,50605,1,4,0)
 ;;=4^I07.9
 ;;^UTILITY(U,$J,358.3,50605,2)
 ;;=^5007051
 ;;^UTILITY(U,$J,358.3,50606,0)
 ;;=I08.0^^193^2496^16
 ;;^UTILITY(U,$J,358.3,50606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50606,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
 ;;^UTILITY(U,$J,358.3,50606,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,50606,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,50607,0)
 ;;=I09.89^^193^2496^17
 ;;^UTILITY(U,$J,358.3,50607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50607,1,3,0)
 ;;=3^Rheumatic Heart Diseases NEC
 ;;^UTILITY(U,$J,358.3,50607,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,50607,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,50608,0)
 ;;=I47.1^^193^2496^24
 ;;^UTILITY(U,$J,358.3,50608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50608,1,3,0)
 ;;=3^Supraventricular Tachycardia
 ;;^UTILITY(U,$J,358.3,50608,1,4,0)
 ;;=4^I47.1
 ;;^UTILITY(U,$J,358.3,50608,2)
 ;;=^5007223
 ;;^UTILITY(U,$J,358.3,50609,0)
 ;;=I48.0^^193^2496^15
 ;;^UTILITY(U,$J,358.3,50609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50609,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,50609,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,50609,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,50610,0)
 ;;=I49.5^^193^2496^23
 ;;^UTILITY(U,$J,358.3,50610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50610,1,3,0)
 ;;=3^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,50610,1,4,0)
 ;;=4^I49.5
 ;;^UTILITY(U,$J,358.3,50610,2)
 ;;=^110404
 ;;^UTILITY(U,$J,358.3,50611,0)
 ;;=I49.8^^193^2496^3
 ;;^UTILITY(U,$J,358.3,50611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50611,1,3,0)
 ;;=3^Cardiac Arrhythmias
 ;;^UTILITY(U,$J,358.3,50611,1,4,0)
 ;;=4^I49.8
